0001209191-23-046578.txt : 20230818 0001209191-23-046578.hdr.sgml : 20230818 20230818164618 ACCESSION NUMBER: 0001209191-23-046578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230816 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Darrel P. CENTRAL INDEX KEY: 0001989794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 231186418 MAIL ADDRESS: STREET 1: C/O VIRACTA THERAPEUTICS, INC. STREET 2: 2533 S. COAST HWY 101, SUITE 210 CITY: CARDIFF STATE: CA ZIP: 92007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viracta Therapeutics, Inc. CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2533 S COAST HWY 101 STREET 2: SUITE 210 CITY: CARDIFF STATE: CA ZIP: 92007 BUSINESS PHONE: 858-400-8470 MAIL ADDRESS: STREET 1: 2533 S COAST HWY 101 STREET 2: SUITE 210 CITY: CARDIFF STATE: CA ZIP: 92007 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 FORMER COMPANY: FORMER CONFORMED NAME: SUNESIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980501 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-16 0 0001061027 Viracta Therapeutics, Inc. VIRX 0001989794 Cohen Darrel P. C/O VIRACTA THERAPEUTICS, INC. 2533 S. COAST HWY 101, SUITE 210 CARDIFF CA 92007 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 1.23 2023-08-16 4 A 0 235000 0.00 A 2033-08-16 Common Stock 235000 235000 D Stock Option (Right to Buy) 1.23 2023-08-16 4 A 0 265000 0.00 A 2033-08-16 Common Stock 265000 265000 D Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023. Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023. /s/ Daniel Chevallard, as Attorny-in-Fact 2023-08-16